The size of an infant at birth, a measure of gestational growth, has been recognized for many years as a biomarker of future risk of morbidity. Both being born small for gestational age (SGA) and being born large for gestational age (LGA), are associated with increased rates of obesity and metabolic disorder, as well as a number of mental disorders including attention deficit/hyperactivity disorder, autism, anxiety, and depression. The common risks raise the question of what neurobiological mechanisms are altered in SGA and LGA offspring. Here we review recent findings allowing for direct comparison of neurobiological outcomes of SGA and LGA in human and animal models. We also present new data highlighting similarities and differences in behavior and neurobiology in our mouse models of SGA and LGA. Overall, there is significant data to support aberrant epigenetic mechanisms, particularly related to DNA methylation, in the brains of SGA and LGA offspring, leading to disruptions in the cell cycle in development and gene expression in adulthood.
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Introduction
Gestation has long been recognized as a critical period for programming lifelong alterations in offspring physiology. Because of this, much attention has been paid to factors influencing gestational quality, and potential markers thereof. One of the most basic outcomes that can be assessed at birth is the size of an infant relative to its gestational age. Infants that are in the bottom 10% of weight for their gestational age (small for gestational age, SGA), even if they are born at term, are at significantly increased risk of mortality and morbidity. These risks include obesity and metabolic disorder, as well as a number of mental disorders such as attention deficit/hyperactivity disorder (ADHD), schizophrenia, depression, anxiety, autism, and developmental (cognitive) delay (Hack et al., 2004; Monset-Couchard et al., 2004; Dahl et al., 2006; Kirkegaard Abbreviations: ADHD, attention deficit/hyperactivity disorder; BDNF, brainderived neurotrophic factor; CNS, central nervous system; DA, dopamine; DAT, dopamine transporter; GWG, gestational weight gain; HF, high-fat; IUGR, intrauterine growth restriction; LGA, large for gestational age; LP, low-protein; MOR, mu-opioid receptor; NAc, nucleus accumbens; PENK, preproenkephalin; PFC, prefrontal cortex; PI3K, phosphoinositide 3-kinase; SGA, small for gestational age; TH, tyrosine hydroxylase; VTA, ventral tegmental area.
* Heinonen et al., 2010; Morsing et al., 2011; Ribeiro et al., 2011; Van Lieshout and Boyle, 2011a; Galéra et al., 2011; Colman et al., 2012; Moore et al., 2012) . For these reasons, SGA, and the risk factors for intrauterine growth restriction (IUGR) that cause SGA, have been the focus of decades of research aimed at increasing positive childhood health outcomes. However, it is not necessarily the case that bigger is better when it comes to gestation. As worldwide obesity rates have begun to rise, research has increasingly focused on children born large for gestational age (LGA) or macrosomic, and/or born to mothers who experienced excessive gestational weight gain (GWG), a risk factor for LGA. Emerging data suggest that LGA is potentially as detrimental as SGA. Children born at over the 90th percentile for weight or born to mothers experiencing excessive GWG are at increased risk of mortality, obesity, metabolic disorder, ADHD, depression, anxiety, autism, and cognitive delay (Herva et al., 2008; Rodriguez, 2010; Tamashiro and Moran, 2010; Alfaradhi and Ozanne, 2011; Halmøy et al., 2011; Ornoy, 2011; Van Lieshout and Boyle, 2011b; Colman et al., 2012; Moore et al., 2012) .
The overlap in the disorders, both physiological and psychological, experienced by SGA and LGA offspring raises important questions about exactly what mechanisms are perturbed in these conditions, and in turn how these mechanisms are apparently similarly provoked by conditions producing grossly disparate early life phenotypes. It is increasingly clear that disordered gestational growth is one sign of substantial alterations in fetal programming, via epigenetic alterations across the developing organism. We have
